← Eichor
Study identifier: NCT05248620 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Prophylactic Antibiotic Treatment in Hemodialysis

Condition: Hemodialysis  ·  Sponsor: Zealand University Hospital

PhaseNA
Planned participants800
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

The purpose of this study is to assess the efficacy of prophylactic antibiotic treatment on blood stream infections and severe culture negative infections, in patients on newly started hemodialysis(HD), with a central venous catheter as vascular access.

This description comes directly from the study's public registry record.

Talk to the study team

Niels E Bruun, Professor  ·  +4525159309  ·  nbru@regionsjaelland.dk

Kasper K Iversen, Professor  ·  Kasper.Karmark.Iversen@regionh.dk

Always discuss trial participation with your own doctor first.

Locations (7)

RigshospitaletCopenhagen, Capital Region, DenmarkNot Yet Recruiting
Herlev-Gentofte HospitalCopenhagen, Capital Region, DenmarkRecruiting
North Zealand Hospital HillerødHillerød, Capital Region, DenmarkNot Yet Recruiting
Aarhus University HospitalAarhus, Middle Region, DenmarkNot Yet Recruiting
Aalborg University HospitalAalborg, North Region, DenmarkRecruiting
ZUH RoskildeRoskilde, Region Sjælland, DenmarkRecruiting
Odense University HospitalOdense, Region South, DenmarkRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT05248620